Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
Auriga Reiterates a 'Buy' on TransDigm (TDG); Investors Missing Value in AmSafe Acquisition
Auriga reiterates a 'Buy' on TransDigm (TDG); Raising PT as Earnings Momentum Continues
Auriga Reiterates a 'Buy' on TransDigm (TDG); Acquisition of AmSafe for Likely to Boost FY12 Adjusted EPS By $0.30
Auriga Starts TransDigm (TDG) at Buy, $100 Price Target